Immuron (IMRN) Depreciation & Amortization (CF) (2019 - 2023)
Immuron's (IMRN) quarterly Depreciation & Amortization (CF) came in at $32523.8 in Q2 2023, up 70.62% year-on-year from $19062.0 in Q2 2022, and up 70.62% quarter-over-quarter from $19062.0 in Q2 2022.
Immuron (IMRN) Depreciation & Amortization (CF) (2019 - 2023) Analysis & Trends
Immuron's Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $32523.8 for Q2 2023.
- On a quarterly basis, Depreciation & Amortization (CF) rose 70.62% year-over-year to $32523.8 in Q2 2023; TTM through Dec 2023 was $32523.8, a 70.62% increase from a year earlier, with the FY2023 full-year figure at $32523.8, up 70.62% from the prior year.
- Depreciation & Amortization (CF) advanced to $32523.8 in Q2 2023 per IMRN's latest filing, from $19062.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $33622.1 in Q2 2021 and bottomed at $5287.0 in Q4 2019.
- The 5-year median for Depreciation & Amortization (CF) is $28875.2 (2020), against an average of $23874.0.
- Across the five-year window, Depreciation & Amortization (CF) plunged 43.31% in 2022 and surged 70.62% in 2023, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $5287.0 in 2019, then surged by 446.15% to $28875.2 in 2020, then rose by 16.44% to $33622.1 in 2021, then plunged by 43.31% to $19062.0 in 2022, then jumped by 70.62% to $32523.8 in 2023.
- Per Business Quant, the three latest IMRN Depreciation & Amortization (CF) figures stand at $32523.8 (Q2 2023), $19062.0 (Q2 2022), and $33622.1 (Q2 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 32,523.76 |
| Jun 30, 2023 | 32,523.76 |
| Jun 30, 2022 | 19,062.05 |
| Jun 30, 2022 | 19,062.05 |
| Jun 30, 2021 | 33,622.15 |
| Jun 30, 2021 | 33,622.15 |
| Jun 30, 2020 | 28,875.21 |
| Jun 30, 2020 | 28,875.21 |
| Dec 31, 2019 | 5,287.00 |
| Dec 31, 2019 | 5,287.00 |